Effects of lidofiazine on left ventricular function in patients

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 11, Issue 1, 1997, Pages 42-48

  De Hert, Stefan G ^a   Rodrigus, Inez E ^a   Haenen, Luc R ^a   Ten Broecke, Pieter W ^a   Boeckxstaens, Christianne J ^a   Gillebert, Thierry C ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

diastolic function; lidoflazine; systolic function

Indexed keywords

LIDOFLAZINE; PLACEBO; SODIUM CHLORIDE; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; HEMODYNAMICS; MIDDLE AGED;

AGED; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; LIDOFLAZINE; MALE; MIDDLE AGED; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 0030614981     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(97)90251-2     Document Type: Article

References (36)

1. Schrader J: Adenosine: A homeostatic metabolite in cardiac energy metabolism. Circulation 81:389-391, 1990
2. Engler RL, Gruber HE: Adenosine: An autocoid, in Fozzard HA, Haber E, Jennings RB, et al (eds): The Heart: An Cardiovascular System. New York, Raven Press, 1992, pp 1745-1764
3. Flameng W, Borgers M, Van der Vusse GJ, et al: Cardioprotective effects of lidoflazine in extensive aorta-coronary bypass grafting. J Thorac Cardiovasc Surg 85:758-768, 1983
4. Akpinar B, Vanermen H, Wellens F: Lidoflazine and myocardial protection. J Thorac Cardiovasc Surg 109:1013-1014, 1995
5. Flameng W, Daenen W, Borgers M, et al: Cardioprotective effects of lidoflazine during 1-hour normothermic global ischemia. Circulation 64:796-807, 1981
6. Suga H, Sagawa K, Shoukas AA: Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circ Res 32:314-322, 1973
7. Little WC, Cheng C, Peterson T, et al: Response of the left ventricular end-systolic pressure-volume relation in conscious dogs to a wide range of contractile states. Circulation 78:736-745, 1988
8. Grossman W, Braunwald E, Mann T, et al: Contractile state of the left ventricle in man as evaluated from end-systolic pressure-volume relations. Circulation 56:845-852, 1977
9. Nivatpumin T, Katz S, Scheuer J: Peak left ventricular systolic pressure/end-systolic volume ratio: a sensitive detector of left ventricular disease. Am J Cardiol 43:969-773, 1979
10. Kass DA, Midei M, Brinker J, et al: Influence of coronary occlusion during PTCA on end-systolic and end-diastolic pressure-volume relations in humans. Circulation 81:447-460, 1990
11. Gorcsan J, Gasior TA, Mandarino WA, et al: Assessment of the immediate effects of cardiopulmonary bypass on left ventricular performance by on-line pressure-area relations. Circulation 89:180-190, 1994
12. Appleyard RF, Glantz SA: Two dimensions describe left ventricular volume change during hemodynamic transients. Am J Physiol 258:H277-284, 1990
13. Smith MD, MacPhail B, Harrison MR, et al: Value and limitations of transesophageal echocardiography in determination of left ventricular volumes and ejection fraction. J Am Coll Cardiol 19:1213-1222, 1992
14. Gorcsan J, Lazar JM, Romand J, et al: On-line estimation of stroke volume using echocardiographic automated border detection in the canine left ventricle. Am Heart J 125:1316-1323, 1993
15. Gardner RM: Direct blood pressure Measurement - Dynamic response requirements. Anesthesiology 54:227-236, 1981
16. Bourdillon PD, Lorell BH, Mirsky I, et al: Increased myocardial stiffness of the left ventricle during pacing-induced ischemia in man. Circulation 67:316-323, 1982
17. Yellin EL, Masatsugu LH, Yoram C, et al: Left ventricular relaxation in the filling and nonfilling canine heart. Am J Physiol 250:H620-629, 1986
18. London MJ, Tubau JF, Wong MG, et al: The natural history of segmental wall motion abnormalities in patients undergoing noncardiac surgery. Anesthesiology 73:644-655, 1990
19. Bloem TJJM, Vermeuelen A, Reneman RS: Lidoflazine in the management of angina pectoris. Clin Cardiol 2:407-412, 1979
20. Ferguson RJ, Côté P, Bourassa MG, et al: Lidoflazine and physical training in the treatment of stable angina pectoris. Clin Cardiol 2:413-418, 1979
21. Nayler WG: The protective effect of Lidoflazine on ischaemic and reperfused heart muscle. R Soc Med Congr Sympos Series 29:79-87, 1980
22. Barry WH, Horowitz JD, Smith TW: Comparison of negative inotropic potency, reversibility, and effects on calcium influx of six calcium channel antagonists in cultured myocardial cells. Br J Pharmacol 85:51-59, 1985
23. Boddeke HWGM, Wilffert B, Heynis JB, et al: A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea pig hearts. Arch Int Pharmacodyn 288:175-186, 1987
24. Boddeke HWGM, Wilffert B, Heynis JB, et al: Investigation of the mechanism of negative inotropic activity of some calcium antagonists. J Cardiovasc Pharmacol 11:321-325, 1988
25. Hugtenburg JG, Mathy MJ, Veldsema-Currie RD, et al: A comparison of the cardioprotective effects of calcium antagonists from different classes upon ischaemic damage in the guinea-pig working heart. Naunyn-Schmiedeberg's Arch Pharmacol 340:126-134, 1989
26. Hugtenburg JG, Mathy MJ, Beckeringh JJ, et al: The differential effect of calcium antagonists on the positive inotropic effects induced by calcium and monensin in cardiac preparations of rats and guinea-pigs. Naunyn-Schmiedeberg's Arch Pharmacol 340:558-566, 1989
27. Hugtenburg JG, Mathy MJ, Boddeke HWGM, et al: Differences between negative inotropic and vasodilator effects of calcium antagonists acting on extra- and intracellular calcium movements in rat and guinea-pig cardiac preparations. Naunyn-Schmiedeberg's Arch Pharmacol 340:567-575, 1989
28. Spedding M: Calcium antagonist subgroups. TIPS 6:109-114, 1985
29. Chang-Chun C, Masuda M, Szabo Z, et al: Nucleoside transport inhibition mediates Lidoflazine-induced cardioprotection during intermittent aortic crossclamping. J Thorac Cardiovasc Surg 104:1602-1609, 1992
30. Schaper WKA, Xhonneux R, Jagenau AHM, et al: The cardiovascular pharmacology of lidoflazine, a long-acting coronary vasodilator. J Pharmacol Exp Ther 152:265-274, 1966
31. De Hert SG, Rodrigus IE, Haenen LR, et al: Recovery of systolic and diastolic left ventricular function early after cardiopulmonary bypass. Anesthesiology 1996 (in press)
32. Rameng W, Sukehiro S, Mölhoff T, et al: A new concept of long-term donor heart preservation: nucleoside transport inhibition. J Heart Lung Transplant 10:990-998, 1992
33. Mölhoff T, Sukehiro S, Van Belle H, et al: Succesfull transplantation after long-term preservation of dog hearts. Anesthesiology 77:291-300, 1992
34. Bolling SF, Groh MA, Mattson AM, et al: Acadesine (AICA-riboside) improves postischemic cardiac recovery. Ann Thorac Surg 54:92-98, 1992
35. Vinten-Johansen J, Nakanishi K, Zhao AQ, et al: Acadesine improves surgical myocardial protection with blood cardioplegia in ischemically injured canine hearts. Circ 88:350-358, 1993
36. Multicenter Study of Perioperative Ischemia (McSPI) Research Group: Effects of Acadesine on the incidence of myocardial infarction and adverse cardiac outcomes after coronary artery bypass graft surgery. Anesthesiology 83:658-673, 1995